Singapore: Biotechnology Industry Organization (BIO) is all set to organize 3rd annual BIO Convention in China, an affil...
Singapore: As the world's largest population, prospects for medical device spending in China is huge. Government healthc...
Singapore: The toxicology facility of WuXi PharmaTech at Suzhou, China, has received a certificate of Good Laboratory Pr...
Singapore: In a bid to strengthen its operations and base in China, German drug maker Merck has said that it is planning...
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...
Singapore: A main suspect in the Chinese economic violations and bribery case involving GlaxoSmithKline has been capture...
Singapore: ScinoPharm has completed construction of its Changshu plant on a 16-acre (6.5-hectare) site in China, which i...
Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...
Singapore: WuXi PharmaTech entered into a contract manufacturing agreement with TaiMed Biologics for the manufacture of...
Singapore: UK Animal health company Zoetis has announced that its joint venture in China has received regulatory approva...
Singapore: World Health Organzination is looking forward to integrate holistic patient care in global healthcare system ...
Singapore: The toxicology facility of WuXi PharmaTech in Suzhou, China, has received a statement of Good Laboratory Prac...
Singapore: Amid constant scrutiny of local operations of drugmakers in China, now Danish drug maker Novo Nordisk was pai...
China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which ...
Singapore: Pharmaron, a premier R&D service provider for the pharmaceutical and biotech industries, has formed a dru...
Singapore: Sinovac Biotech, a provider of biopharmaceutical products in China, has appointed Mr Danny Chung as chief f...
While many multinational companies have reduced their manpower to cut costs in 2011, regional companies in Asia have gon...
Singapore: US based Neurotez intends to develop Leptin derivatives for the treatment of Alzheimer's disease (AD) and oth...